Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CRNX |
---|---|---|
09:32 ET | 3468 | 45.8 |
09:34 ET | 100 | 45.54 |
09:36 ET | 700 | 45.2 |
09:38 ET | 500 | 45.195 |
09:39 ET | 100 | 45.195 |
09:41 ET | 1710 | 45.46 |
09:43 ET | 1380 | 45.56 |
09:45 ET | 300 | 45.65 |
09:48 ET | 600 | 45.525 |
09:50 ET | 500 | 45.52 |
09:52 ET | 10014 | 45.07 |
09:54 ET | 3145 | 44.95 |
09:56 ET | 300 | 44.83 |
09:57 ET | 3048 | 44.5 |
09:59 ET | 1999 | 44.54 |
10:01 ET | 2564 | 44.675 |
10:03 ET | 700 | 44.675 |
10:06 ET | 8388 | 44.46 |
10:08 ET | 5400 | 44.29 |
10:10 ET | 10774 | 44.31 |
10:12 ET | 9410 | 44.17 |
10:14 ET | 2936 | 44.4 |
10:15 ET | 3503 | 44.445 |
10:17 ET | 5529 | 44.72 |
10:19 ET | 850 | 45.16 |
10:21 ET | 780 | 45.29 |
10:24 ET | 500 | 45.41 |
10:26 ET | 2950 | 45.26 |
10:28 ET | 900 | 45.1 |
10:30 ET | 400 | 44.99 |
10:32 ET | 500 | 44.99 |
10:33 ET | 1300 | 44.995 |
10:35 ET | 3863 | 45.11 |
10:37 ET | 900 | 45.015 |
10:39 ET | 300 | 44.97 |
10:42 ET | 239 | 44.982 |
10:44 ET | 2900 | 45.155 |
10:46 ET | 800 | 45.1 |
10:48 ET | 800 | 45.17 |
10:50 ET | 1159 | 45.19 |
10:51 ET | 100 | 45.24 |
10:53 ET | 2049 | 44.88 |
10:55 ET | 893 | 44.96 |
10:57 ET | 100 | 44.98 |
11:00 ET | 2018 | 44.95 |
11:02 ET | 1200 | 45.005 |
11:04 ET | 1600 | 45.05 |
11:06 ET | 1000 | 44.96 |
11:08 ET | 500 | 44.975 |
11:09 ET | 800 | 45.06 |
11:11 ET | 300 | 45.08 |
11:13 ET | 1250 | 45.04 |
11:15 ET | 3722 | 45.05 |
11:18 ET | 500 | 45.01 |
11:20 ET | 800 | 45.045 |
11:22 ET | 100 | 45.045 |
11:24 ET | 1561 | 45.045 |
11:26 ET | 900 | 45.09 |
11:27 ET | 1700 | 45.03 |
11:29 ET | 900 | 45.06 |
11:31 ET | 1157 | 45.01 |
11:33 ET | 1944 | 44.88 |
11:36 ET | 400 | 44.855 |
11:40 ET | 1017 | 44.89 |
11:42 ET | 1571 | 44.765 |
11:45 ET | 600 | 44.65 |
11:47 ET | 700 | 44.685 |
11:51 ET | 400 | 44.58 |
11:54 ET | 1291 | 44.455 |
11:58 ET | 200 | 44.495 |
12:00 ET | 500 | 44.58 |
12:02 ET | 200 | 44.57 |
12:03 ET | 800 | 44.69 |
12:05 ET | 1349 | 44.64 |
12:07 ET | 2900 | 44.59 |
12:09 ET | 100 | 44.68 |
12:14 ET | 550 | 44.69 |
12:16 ET | 600 | 44.605 |
12:18 ET | 1200 | 44.54 |
12:21 ET | 100 | 44.57 |
12:23 ET | 300 | 44.67 |
12:25 ET | 100 | 44.62 |
12:27 ET | 300 | 44.63 |
12:30 ET | 1293 | 44.54 |
12:32 ET | 400 | 44.575 |
12:34 ET | 1300 | 44.61 |
12:36 ET | 329 | 44.61 |
12:38 ET | 1778 | 44.485 |
12:39 ET | 600 | 44.448 |
12:41 ET | 434 | 44.42 |
12:43 ET | 804 | 44.4 |
12:45 ET | 1200 | 44.26 |
12:48 ET | 4561 | 44.425 |
12:50 ET | 100 | 44.43 |
12:52 ET | 1029 | 44.47 |
12:54 ET | 2101 | 44.54 |
12:56 ET | 3336 | 44.44 |
12:57 ET | 5755 | 44.37 |
12:59 ET | 27594 | 44.2 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Crinetics Pharmaceuticals Inc | 3.5B | -11.7x | --- |
Dyne Therapeutics Inc | 3.4B | -8.6x | --- |
Merus NV | 3.6B | -19.4x | --- |
Immunovant Inc | 3.8B | -13.9x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Avidity Biosciences Inc | 3.9B | -12.6x | --- |
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.5B |
---|---|
Revenue (TTM) | $2.0M |
Shares Outstanding | 78.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.68 |
EPS | $-3.77 |
Book Value | $7.91 |
P/E Ratio | -11.7x |
Price/Sales (TTM) | 1,765.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -12,571.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.